AI Buyer Insights:

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Aardvark Therapeutics Data, Technology Stack, and Enterprise Applications
Collaboration
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2020 2020
Content Management
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Onit Legacy Onit SecureDocs Content Management Content Management n/a 2019 2019
In 2019, Aardvark Therapeutics deployed Onit SecureDocs as a Content Management solution on its website, provisioning a web accessible secure document repository at aardvarktherapeutics.securedocs.com. The Onit SecureDocs implementation serves as the company level content management layer for controlled external document sharing, centralized storage, and regulated access for a small life sciences organization. Configuration focuses on document access control, role based permissions, version control, and audit logging, with the Onit SecureDocs application providing administrative controls for user provisioning and document lifecycle management. Operational scope is company wide, supporting legal, research and operations workflows through browser based access, and the deployment emphasizes structured permissioning and auditability as primary governance mechanisms.
CRM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Automattic Legacy Automattic Jetpack CRM CRM CRM n/a 2023 2023
IaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Content Delivery Network IaaS 2023 2023
IT Decision Makers and Key Stakeholders at Aardvark Therapeutics
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by Aardvark Therapeutics Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Aardvark Therapeutics Technographics

Aardvark Therapeutics is a Life Sciences organization based in United States, with around 30 employees and annual revenues of $4.0 million.

Aardvark Therapeutics operates a diverse technology stack with applications such as Microsoft 365, Onit SecureDocs and Automattic Jetpack CRM, covering areas like Collaboration, Content Management and CRM.

Aardvark Therapeutics has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Microsoft, Onit and Automattic.

Aardvark Therapeutics recently adopted applications including Automattic Jetpack CRM in 2023, Cloudflare CDN in 2023 and Microsoft 365 in 2020, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Aardvark Therapeutics’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Aardvark Therapeutics’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Aardvark Therapeutics technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.